Works by Nam, Ah-Rong

Results: 10

Therapeutic potential of BOLD-100, a GRP78 inhibitor, enhanced by ATR inhibition in pancreatic ductal adenocarcinoma.

Published in:

Cell Communication & Signaling, 2025, v. 23, n. 1, p. 1, doi. 10.1186/s12964-025-02242-8

By:

Lee, Su In;
Nam, Ah-Rong;
Oh, Kyoung-Seok;
Kim, Jae-Min;
Bang, Ju-Hee;
Jeong, Yoojin;
Choo, Sea Young;
Kim, Hyo Jung;
Yoon, Jeesun;
Kim, Tae-Yong;
Oh, Do-Youn

Publication type:

Article

GC1118, a novel anti-EGFR antibody, has potent KRAS mutation-independent antitumor activity compared with cetuximab in gastric cancer.

Published in:

Gastric Cancer, 2019, v. 22, n. 5, p. 932, doi. 10.1007/s10120-019-00943-x

By:

Park, Ji Eun;
Jin, Mei Hua;
Hur, Minkyu;
Nam, Ah-Rong;
Bang, Ju-Hee;
Won, Jonghwa;
Oh, Do-Youn;
Bang, Yung-Jue

Publication type:

Article

Prognostic implication of antitumor immunity measured by the neutrophil-lymphocyte ratio and serum cytokines and angiogenic factors in gastric cancer.

Published in:

Gastric Cancer, 2017, v. 20, n. 2, p. 254, doi. 10.1007/s10120-016-0613-5

By:

Lee, Kyung-Hun;
Han, Sae-Won;
Im, Seock-Ah;
Kim, Tae-You;
Bang, Yung-Jue;
Oh, Do-Youn;
Ock, Chan-Young;
Kim, Tae-Yong;
Nam, Ah-Rong;
Bang, Ju-Hee;
Lee, Joongyub

Publication type:

Article

Signature of cytokines and angiogenic factors (CAFs) defines a clinically distinct subgroup of gastric cancer.

Published in:

Gastric Cancer, 2017, v. 20, n. 1, p. 164, doi. 10.1007/s10120-015-0583-z

By:

Ock, Chan-Young;
Nam, Ah-Rong;
Bang, Ju-Hee;
Kim, Tae-Yong;
Lee, Kyung-Hun;
Han, Sae-Won;
Im, Seock-Ah;
Kim, Tae-You;
Bang, Yung-Jue;
Oh, Do-Youn

Publication type:

Article

The prognostic role of soluble transforming growth factor‐β and its correlation with soluble programmed death‐ligand 1 in biliary tract cancer.

Published in:

Liver International, 2021, v. 41, n. 2, p. 388, doi. 10.1111/liv.14636

By:

Kim, Jin Won;
Lee, Kyung‐Hun;
Kim, Ji‐Won;
Suh, Koung Jin;
Nam, Ah‐Rong;
Bang, Ju‐Hee;
Jin, Mei Hua;
Oh, Kyoung‐Seok;
Kim, Jae‐Min;
Kim, Tae‐Yong;
Oh, Do‐Youn

Publication type:

Article

The prognostic role of soluble TGF‐beta and its dynamics in unresectable pancreatic cancer treated with chemotherapy.

Published in:

Cancer Medicine, 2020, v. 9, n. 1, p. 43, doi. 10.1002/cam4.2677

By:

Park, Hyunkyung;
Bang, Ju‐Hee;
Nam, Ah‐Rong;
Park, Ji Eun;
Jin, Mei Hua;
Bang, Yung‐Jue;
Oh, Do‐Youn

Publication type:

Article

Prognostic implications of soluble programmed death-ligand 1 and its dynamics during chemotherapy in unresectable pancreatic cancer.

Published in:

Scientific Reports, 2019, v. 9, n. 1, p. N.PAG, doi. 10.1038/s41598-019-47330-1

By:

Park, Hyunkyung;
Bang, Ju-Hee;
Nam, Ah-Rong;
Eun Park, Ji;
Hua Jin, Mei;
Bang, Yung-Jue;
Oh, Do-Youn

Publication type:

Article

Enhanced antitumor effect of binimetinib in combination with capecitabine for biliary tract cancer patients with mutations in the RAS/RAF/MEK/ERK pathway: phase Ib study.

Published in:

2019

By:

Kim, Jin Won;
Lee, Kyung-Hun;
Kim, Ji-Won;
Suh, Koung Jin;
Nam, Ah-Rong;
Bang, Ju-Hee;
Bang, Yung-Jue;
Oh, Do-Youn

Publication type:

journal article

WEE1 inhibition reverses trastuzumab resistance in HER2-positive cancers.

Published in:

Gastric Cancer, 2021, v. 24, n. 5, p. 1003, doi. 10.1007/s10120-021-01176-7

By:

Jin, Mei-Hua;
Nam, Ah-Rong;
Bang, Ju-Hee;
Oh, Kyoung-Seok;
Seo, Hye-Rim;
Kim, Jae-Min;
Yoon, Jeesun;
Kim, Tae-Yong;
Oh, Do-Youn

Publication type:

Article

Immunomodulatory effects of trastuzumab deruxtecan through the cGAS-STING pathway in gastric cancer cells.

Published in:

Cell Communication & Signaling, 2024, v. 22, n. 1, p. 1, doi. 10.1186/s12964-024-01893-3

By:

Oh, Kyoung-Seok;
Nam, Ah-Rong;
Bang, Ju-Hee;
Jeong, Yoojin;
Choo, Sea Young;
Kim, Hyo Jung;
Lee, Su In;
Kim, Jae-Min;
Yoon, Jeesun;
Kim, Tae-Yong;
Oh, Do-Youn

Publication type:

Article